Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Telix Pharmaceuticals Limited ADR (TLX)

Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Telix Pharmaceuticals Limited ADR 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 AUS

https://telixpharma.com Employees: 554 P: 61-3-9093-3855

Sector:

Medical

Description:

Telix Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Th company is developing a portfolio of clinical and commercial stage products which aims to address significant unmet medical needs in oncology and rare diseases. Telix Pharmaceuticals Limited, formerly known as TLX PHARMACEUT, is based in MELBOURNE, Australia.

Key Statistics

Overview:

Market Capitalization, $K 2,628,801
Enterprise Value, $K 2,536,751
Shares Outstanding, K 338,763
Float, K 338,763
% Float 100.00%
Short Interest, K 78
Short Float 0.02%
Days to Cover 1.00
Short Volume Ratio 0.53

Financials:

Annual Sales, $ 516,680 K
Annual Net Income, $ 32,930 K
EBIT, $ 0 K
EBITDA, $ 59,470 K

Growth:

1-Year Return -51.50%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/19/26
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Year 7.20%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 04/18/06
Dividend Payout Ratio 0.00%

TLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 25.62
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 6.37%
Debt/Equity 1.00
Price/Sales 4.26
Price/Cash Flow 65.07
Price/Book 6.63
Book Value/Share 1.12
Interest Coverage 2.52
60-Month Beta 0.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar